Look Below the Surface

With Molecular Testing

Diagnosis and Determination of Advanced Lesions in Pancreatic Cysts Through Endoscopic Ultrasound and Cyst Fluid Analysis

Click the chapter icon () or the timestamp markers (

) within the control bar to navigate this video's chapters

A Multigenerational Approach to Pancreatic Cancer and Cystic Precursors

View Video

Request Information

If you are a physician and would like to learn more about PancraGEN^®, PanDNA^®, or Interpace Diagnostics services, you can reach us using the form below.

I am interested in:

Interest

Learning more about PancraGEN/PanDNA Understanding how to order and use test collection materials Requesting a visit from my representative Other

NPI

(Needed for verification purposes to allow representative follow‑up)

Name

Phone Number

Zip Code

Limitations and Disclaimers¹
Although PancraGEN is highly specific for malignancy, some malignant cysts may not be detected. There may also be individuals who are falsely identified as having a malignant cyst. Diagnosis and appropriate patient management are the responsibility of the referring physician or healthcare provider.

Reference 1. Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47(2):136-142.

Look Below the Surface

With Molecular Testing

Diagnosis and Determination of Advanced Lesions in Pancreatic Cysts Through Endoscopic Ultrasound and Cyst Fluid Analysis

Related Videos

A Multigenerational Approach to Pancreatic Cancer and Cystic Precursors

PancraGEN Overview

Pancreatic Cyst Dilemmas

Request Information